Posts Tagged ‘Scientific’
Denver, CO (PRWEB) September 20, 2012
Schumacher Group, one of the nations fastest growing emergency medicine management companies, will be hosting a variety of events, sponsorships and speakers at the 2012 ACEP Scientific Assembly in Denver, Oct. 8-10.
Before the official start of the ACEP event, SG will be sponsoring, along with Blue Jay Consulting and MedicAlert, this years Urgent Matters conference a seminar that occurs in conjunction with the Scientific Assembly as a one day session on Oct. 7. The focus is on health care policies, the new era of health care reform, and how changes will affect emergency department patient flow across the U.S., with guest speakers including Mark McClelland, DNP, RN and Assistant Research Professor at George Washington University; Brent R. Asplin, MD, President of Fairview Clinics in Minnesota; Suzanne Stone-Griffith, RN, Hospital Corporation of America (HCA); Blue Jay Consultings Chief Nursing Executive Jim Hoelz, MS, MBA, RN, CEN, FAEN; and Jesse Pines, MD, MBA. (*Attendance information to follow in Editors Notes.)
Following Urgent Matters, Schumacher Group will be present at the following events:
EMRA (Emergency Medicine Residency Association) Luncheon
Monday, Oct. 8, (11:50am 1pm) Sheraton Hotel – Mile High Ballroom – 4A
FEATURED SPEAKER: Mark A. Mitchell, DO, FACOEP, President – Emergency Medicine Division, Schumacher Group
Presenting: Your First EM Job: What Are You Looking For?
EMRA Job Fair
Monday, Oct. 8 (5 7pm) Colorado Convention Center – Mile High Ballroom – 3
AAWEP (American Association of Women Emergency Physicians) Breakfast
Monday, Oct. 8 (7:30 – 10:30am) Sheraton Hotel – Governor’s Square 10, Concourse Level
FEATURED SPEAKER: Beverly Gladney, MD, FACEP, Regional Medical Officer, Schumacher Group
Topic: Be Heard! Get Elected! EM womens roles in politics, hospital committees, boards, and more.
Emergency Medicine and Health System Reform Panel: What is EM’s True Value?
Wednesday, October 10 (4 6pm) Colorado Convention Center, Room 405
FEATURED PANELIST: Randy Pilgrim, MD, FACEP, CEO and Chief Medical Officer, Schumacher Group
Co-Presenting: Delivery System Reform
ACEP is a remarkable champion, not only for emergency physician practices, but also for the healthcare delivery system as a whole, stated Randy Pilgrim, MD, FACEP, CEO & Chief Medical Officer of Schumacher Group. We are proud to support this years event in such a meaningful way.
For additional details regarding the ACEP Scientific Assembly, visit http://www.acep.org. For additional information about Schumacher Group, visit schumachergroup.com or follow SG on Facebook at facebook.com/Schumachergroupcareers.
Caring for some 4 million patients annually, Schumacher Group is one of the largest emergency medical staffing and management companies in the U.S., as well as a health care resource for Hospital Medicine, Wellness Programs, Care Management, Urgent Care, Physical Therapy, and Billing & Coding. For more information, visit http://www.schumachergroup.com.
To attend the Oct. 7 Urgent Matters event, there is a registration fee of $ 75; but there is limited seating of 150 participants for the event. You do not have to be registered for the entire ACEP conference to attend, but pre-registration and payment is required. ACEP Delegates can attend Urgent Matters free of charge, but must pre-register. All other ACEP events are included in your ACEP registration.
Incoming search terms:
Phoenix, AZ (PRWEB) May 09, 2012
National Scientific Corporation (Pink Sheets: NSCT) announced today that it has hired S E Clark & Company, P.C. to provided SEC PCAOB auditing services and has also changed its name to Cloud Medical Doctor Software Corporation (Cloud-MDs) effective immediately. Michael DeLaGarza, CEO of National Scientific Corporation, stated that the hiring of S E Clark & Company, P C will start the process of bring the company into full reporting compliance with the SEC. Also, the name change will better represent the new direction of the companys medical software business. Our new software will be available on May 10, 2012 on two platforms: a standalone web application and an integrated application into the companys soon to be release Cloud application (http://www.cloud-mds.com).
Cloud-MDs is a Cloud Based, 5010 and ICD-10 compliant, medical software solution and service, designed by experienced healthcare programers for healthcare providers, that produces Actionable Information to help Independent Physician Practices, New Care Delivery Models (ACO), Healthcare Systems and Billing Services optimize a wide range of business processes resulting in, Increased Profits, Higher Quality, Greater Efficiency, Noticeable Cost Reductions and Better Patient Care. In this era of tighter controls on healthcare spending, continued downward pressure on reimbursements by insurance companies, the lack of reliable patient balance management and unsustainable cost levels, providers are looking for new ways to remain competitive. Cloud-MDs offers Providers the tools, organization and knowledge required to accomplish these critical items and still do what they love practice medicine while simultaneously improving the health of their medical business. Major components of this ground breaking solution include Practice Management, Electronic Health Care Records, Revenue Management and a Business Intelligence (BI) Dash board.
For further information about Cloud Medical Doctor Software Corporation go to http://www.cloud-mds.com or mdlg(at)cloud-mds(dot)com.
Certain statements in this press release that are not historical facts are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be identified by the use of words such as “anticipate,” “believe,” “expect,” “future,” “may,” “will,” “would,” “should,” “plan,” “projected,” “intend,” and similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of National Scientific Corporation (the Company) to be materially different from those expressed or implied by such forward-looking statements. The Company’s future operating results are dependent upon many factors, including but not limited to the Company’s ability to: (i) defend sell its software; (ii) build the management and human resources and infrastructure necessary to support the growth of its business; (iii) competitive factors and developments beyond the Company’s control; and (iv) other risk factors discussed in the Company’s periodic filings with the Securities and Exchange Commission, which are available for review at http://www.sec.gov under “Search for Company Filings.”
Incoming search terms:
- affordable care act section 2521 p 1001 national medical device registry
- Chip Implant maker Pink Sheets
Scientific instrument maker Thermo Fisher Scientific Inc. said Monday that it has completed its previously announced purchase of Lomb Scientific, which makes chemicals, consumables and instruments.
All News, Video and Posts related to SECTOR: Health Care
Scientific instrument maker Thermo Fisher Scientific Inc. said Tuesday it agreed to buy Lomb Scientific, which sells laboratory chemicals, consumables, and instruments in Australia and New Zealand.
All News, Video and Posts related to SECTOR: Health Care
MicroPort Scientific’s shares soared on its Hong Kong debut, up more than 25% from its IPO price of HK$6.10. Philip Li Wang, COO at MicroPort Scientific, gives CNBC’s Chloe Cho an insight into the company’s future plans.
MicroPort Scientific Soars in HK Debut
Access Scientific Partners with Teleflex to Launch PICC WAND
SAN DIEGO—-Access Scientific has partnered with Teleflex Incorporated to launch the new PICC WAND™, which enables clinicians to insert a peelable sheath for PICC or midline catheter placement using the new Accelerated Seldinger Technique .
Read more on Business Wire via Yahoo! Finance
The Food and Drug Administration said Thursday it approved three implantable heart devices from Boston Scientific Corp. for a new use in treating heart failure patients.
FDA expands approval of implants for heart failure